Furthermore, when examined by qPCR, we found that the expression of immune-promoting cytokines (TNF-α, IL-1β and IFN-γ) in SU4312-treated tumor tissues was significantly higher than that in the control group (Figure 6G). The gene discussed is IFNG; the disease is neoplasm.